Cathepsins as effector proteases in hepatocyte apoptosis

Cell Biochemistry and Biophysics

Volumn 30, Issue 1, 1999, Pages 71-88

  Roberts, Lewis R ^a   Adjei, Philip N ^a   Gores, Gregory J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bile salts; Cathepsin B; Cathepsin D, Hepatocellular carcinoma; Topoisomerase inhibitors

Indexed keywords

BILE ACID; CAMPTOTHECIN; CATHEPSIN B; CATHEPSIN D; COMPLEMENTARY DNA; PEPSTATIN; PROTEINASE; PROTEINASE INHIBITOR; STREPTOMYCES PEPSIN INHIBITOR;

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; CELL CULTURE; LIVER; METABOLISM; PHYSIOLOGY; RAT; REVIEW;

ANIMALS; APOPTOSIS; BILE ACIDS AND SALTS; CAMPTOTHECIN; CATHEPSIN B; CATHEPSIN D; CELLS, CULTURED; DNA, ANTISENSE; ENDOPEPTIDASES; LIVER; MODELS, BIOLOGICAL; PEPSTATINS; PROTEASE INHIBITORS; RATS;

EID: 0032601582     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02737885     Document Type: Article

References (43)

1. Kerr, J. F. R. (1971) Shrinkage necrosis: a distinct mode of cellular death. J. Pathol. 105, 13-20.
2. Kerr, J. F. R., Wyllie, A. H., and Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
3. Wyllie, A. H., Kerr, J. F. R., and Currie, A. R. (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68, 251-306.
4. Fraser, A. and Evan, G. (1996) A license to kill. Cell 85, 781-784.
5. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffaldi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E., and Dixit, V. M. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827.
6. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., and Wallach, D. (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in a Fas/APO-1- and TNF receptor-induced cell death. Cell 85, 803-815.
7. Leist, M., Single, B., Kunstle, G., Volbracht, C., Hentze, H., and Nicotera, P. (1997) Apoptosis in the absence of poly-(ADP-ribose) polymerase. Biochem. Biophys. Res. Commun. 233, 518-522.
8. Patel, T., Gores, G. J., and Kaufmann, S. H. (1996) The role of proteases during apoptosis. FASEB J. 10, 587-597.
9. Deiss, L. P., Galinka, H., Berissi, H., Cohen, O., and Kimchi, A. (1996) Cathepsin D protease mediates programmed cell death induced by interferon-g, Fas/APO-1 and TNF-a. EMBO J. 15, 3861-3870.
10. Lotem, J. and Sachs, L. (1996) Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents. Proc. Natl. Acad. Sci. USA 93, 12,507-12,512.
11. Tenniswood, M. P., Guenette, R. S., Lakins, J., Mooibroek, M., Wong, P., and Welsh, J-E. (1992) Active cell death in hormone dependent tissues. Cancer Metastasis Rev. 11, 192-219.
12. Nitatori, T., Sato, N., Waguri, S., Karasawa, Y., Araki, H., Shibanai, K., Kominami, E., and Uchiyama, Y. (1995) Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J. Neurosci. 15, 1001-1011.
13. Hill, I. E., Preston, E., Monette, R., and MacManus, J. P. (1997) A comparison of cathepsin B processing and distribution during neuronal death in rats following global ischemia or decapitation necrosis. Brain Res. 751, 206-216.
14. Taniguchi, K., Sato, N., and Uchiyama, Y. (1995) Apoptosis and heterophagy of medial edge epithelial cells of the secondary palatine shelves during fusion. Arch. Histol. Cytol. 58, 191-203.
15. Greim, H., Trulzsch, D., Roboz, J., Dressler, K., Czygan, P., Hutterer, F., Schaffner, F., and Popper, H. (1972) Mechanism of cholestasis. 5. Bile acids in normal rat livers and in those after bile duct ligation. Gastroenterology 63, 837-845.
16. Greim, H., Trulzsch, D., Czygan, P., Rudick, J., Hutterer, F., Schaffner, F., and Popper, H. (1972) Mechanism of cholestasis. 6. Bile acids in human livers with or without biliary obstruction. Gastroenterology 63, 846-850.
17. Schumucker, D. L., Ohta, M., Kanai, S., Sato, Y., and Kitani, K. (1990) Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 12, 1216-1221.
18. Poupon, R., Balkan, B., Eschwege, E., and Poupon, P. (1991) A multicenter controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N. Engl. J. Med. 324, 1548-1554.
19. Patel, T., Bronk, S. F., and Gores, G. J. (1994) Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in hepatocytes. J. Clin. Invest. 94, 2183-2192.
20. Kurosawa, H., Que, F. G., Roberts, L. R., Fesmier, P. J., and Gores, G. J. (1997) Hepatocytes in the bile duct ligated rat express Bcl-2: a potential mechanism to inhibit apoptosis by toxic bile salts. Am. J. Physiol. 272, G1587-G1593.
21. Kwo, P., Patel, T., Bronk, S. F., and Gores, G. J. (1995) Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes. Am. J. Physiol. 268, G613-G621.
22. Roberts, L. R., Kurosawa, H., Bronk, S. F., Fesmier, P. J., Agellon, L. B., Leung, W.-Y., Mao, F., and Gores, G. J. (1997) Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology 113, 1714-1726.
23. Kirschke, H., Barrett, A. J., and Rawlings, N. D. (1995) Proteinases 1: Lysosomal cysteine proteinases. Prot. Profile 2, 1587-1591.
24. McKay, M. J., Offermann, M. K., Barrett, A. J., and Bond, J. S. (1983) Action of human liver cathepsin B on the oxidized insulin B chain. Biochem. J. 213, 467-471.
25. Mort, J. S. and Recklies, A. D. (1986) Interrelationship of active and latent secreted human cathepsin B precursors. Biochem. J. 233, 57-63.
26. Authier, F., Mort, J. S., Bell, A. W., Posner, B. I., and Bergeron, J. J. (1995) Proteolysis of glucagon within hepatic endosomes by membrane-associated cathepsins B and D. J. Biol. Chem. 270, 15,798-15,807.
27. Spiess, E., Bruning, A., Gack, S., Ulbricht, B., Spring, H., Trefz, G., and Ebert, W. (1994) Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level. J. Histochem. Cytochem. 42, 917-929.
28. Mizuochi, T., Yee, S-T., Kasai, M., Kakiuchi, T., Muno, D., and Kominami, E. (1994) Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain. Immunol. Lett. 43, 189-193.
29. Towatari, T., Nikawa, T., Murata, M., Yokoo, C., Tamai, M., Hanada, K., and Katunuma, N. (1991) Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo. FEBS Lett. 280, 311-315.
30. Torchia, E. C., Shapiro, R. J., and Agellon, L. B. (1996) Reconstitution of bile acid transport in the rat hepatoma McArdle RH-7777 cell line. Hepatology 24, 206-211.
31. Mach, L., Mort, J. S., and Glossl, J. (1994) Maturation of human procathepsin B. J. Biol. Chem. 269, 13,030-13,035.
32. Mach, L., Schwihla, H., Stuwe, K., Rowan, A. D., Mort, J. S., and Glossl, J. (1993) Activation of procathepsin B in human hepatoma cells: the conversion into the mature enzyme relies on the action of cathepsin B itself. Biochem. J. 293, 437-442.
33. Nishimura, Y., Kawabata, T. and Kato, K. (1988) Identification of latent procathepsi,ns B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro. Arch. Biochem. Biophys. 261, 64-71.
34. Rowan, A. D., Mason, P., Mach, L., and Mort, J. S. (1992) Rat procathepsin B: proteolytic procession to the mature form in vitro. J. Biol. Chem. 267, 15,993o15,999.
35. Shields, P. P., Gonzales, T. A., Charles, D., Gilligan, J. P., and Stern, W. (1991) Accumulation of pepstatin in cultured eridothelial cells and its effect on endothelial processing. Biochem. Biophy. Res. Commun. 177, 1006-1012.
36. Roberts, L. R., Bronk, S. F., and Gores, G. J. (1997) Effector proteases in bile salt-induced hepatocyte apoptosis, in Bile Acids in Hepatobiliary Diseases - Basic Research and Clinical Application, Falk Symposium Series 93, 265-271.
37. Jones, B. A., Rao, Y.-P., Stravitz, R. T., and Gores, G. J. (1997) Bile salt-induced apoptosis of hepatocytes involves activation of protein kinase C. Am. J. Physiol. 272, G1109-G1115.
38. Grasl-Kraupp, B., Ruttkay-Nedecky, B., Mullauer, L., Taper, H., Huber, W., Bursch, W., and Schulte-Hermann, R. (1997) Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology 25, 906-912.
39. Liu, L. F. (1989) DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58, 351-376.
40. Adjei, P. N., Kaufmann, S. H., Leung, W. Y., Mao, F., and Gores, G. J. (1996) Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32. J. Clin. Invest. 98, 2588-2596.
41. Faubion, W. A., Roberts, P. J., Bronk, S. F., Agellon, L. B., and Gores, G. J. A unique caspase 8-cathepsin B protease cascade contributes to bile salt-induced apoptosis. Gastroenterology (abstract), in press.
42. Zhou, Q., Snipas, S., Orth, K., Mazio, M., Dixit, V. M., and Salvesen, G. S. (1997) Target protease specificity of the viral serpin crm A. J. Biol. Chem. 272, 7797-7800.
43. Sarin, A., Wu, M. L., and Henkart, P. A. (1996) Different interleukin-1 beta converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J. Exp. Med. 184, 2445-2450.